Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Ann Neurol. 2014 Jul 10;76(4):541–549. doi: 10.1002/ana.24214

Figure 3.

Figure 3

Individual LVESV measurements for subjects randomized to sildenafil (black lines with squares) and placebo (gray lines with circles) treatment groups over time. The dashed lines signify the periods that subjects were taking placebo.